BioSpace News Archive

Mitsubishi Chemical Holdings Corporation announced that, at the meeting of its Board of Directors held , it resolved change of representative corporate executive officers as outlined below.

Save the date for Swedish Orphan Biovitrum AB Capital Markets Day on 10 December 2020.

Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, announced that the U.S. Food and Drug Administration has granted Orphan Drug Designations for KZR-616 for the treatment of polymyositis and dermatomyositis.

Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors and tumor metastases, today announced it will report financial results for its second fiscal quarter ended September 30, 2020

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, today announced that its third quarter 2020 financial results will be released on Friday, November 6, 2020

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), is pleased to announce it has signed a Material Transfer Agreement (“Agreement”) with the University Hospital Pilsen, Czech Republic to enable an investigator-initiated randomized Phase II clinical trial evaluating its lead product candidate eftilagimod alpha (“efti” or “IMP321”) in hospitalized patients with COVID-19

Marc Schegerin, MD and Sapna Srivastava, PhD join as new board members and Micah Zajic as Chief Business Officer

VANGARD trial discontinued due to evolving COVID-19 treatment landscape, recent feedback from FDA regarding regulatory and development path, and interim analysis of trial data Enrollment expected to resume for ongoing Phase 2b trial of pemziviptadil in pulmonary arterial hypertension (PAH)

GI Supply today announced the FDA clearance of EverLift™ Submucosal Lifting Agent in a 10mL syringe , a new device for the lift of polyps, adenomas, early-stage cancers and other gastrointestinal lesions prior

Cleure, the leading clean and hypoallergenic personal care brand for sensitivities, is expanding its product line with the launch of their new Mineral SPF 30 Sunscreen. Formulated with non-micro